As the COVID-19 pandemic continues, it is important to be vigilant for other emergent concerns in infectious disease. The monkeypox epidemic has come under control due to effective education and a widespread vaccination program, but pockets of the disease still exist. Polio reemerged in New York, showing that an “extinct” disease can still gain purchase in undervaccinated communities. In the wake of COVID-19, many health authorities warn of a resurgent flu season. In addition, our methods of disease prevention have changed to meet concerns of resistance and to ensure both prevention and treatment adherence, from modified TB regimens to updated vaccination recommendations to guidance on managing treatment-resistant pathogens.
This presentation will focus on recognition and management of diseases that became emergent concerns in 2022, as well as updates in the fields of disease management and prevention, such as hospital-associated infections, ABSSSIs, and vaccines for COVID and other conditions.